AGP
MRNA icon

Artia Global Partners’s Moderna MRNA Stock Holding History

Artia Global Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-23,800
Closed -$615K – 64
2025
Q3 		$615K Buy
+23,800
New +$664K 0.1% 47
2023
Q3 		– Sell
-84,719
Closed -$10.3M – 31
2023
Q2 		$10.3M Hold
84,719
– – 3.55% 7
2023
Q1 		$13M Buy
84,719
+10,000
+13% +$1.65M 4.81% 7
2022
Q4 		$13.4M Buy
+74,719
New +$12.2M 5.11% 7

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artia Global Partners's MRNA Position: Q4 2025 in Review

Artia Global Partners sold out of Moderna (MRNA) in Q4 2025, closing a stake of 23,800 shares — an estimated $615K sold.

Artia Global Partners first reported a position in MRNA in Q4 2022 and held it in 4 quarters. The position peaked at $13.4M in Q4 2022. 672 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • Artia Global Partners reported no remaining Moderna position as of Q4 2025 after selling out during the quarter.
  • Artia Global Partners sold 23,800 Moderna shares in Q4 2025, an estimated $615K.
  • Artia Global Partners first reported a position in Moderna in Q4 2022 and held it in 4 quarters.
  • Artia Global Partners's Moderna position peaked at $13.4M in Q4 2022.
  • 672 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on Artia Global Partners's 13F filing for Q4 2025, filed 17 Feb 2026.